Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. - sprookjes - yvandenbroek - TriplyDB

Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.

Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.

http://www.wikidata.org/entity/Q30352821

about

3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction A novel cardiac muscle-derived biomaterial reduces dyskinesia and postinfarct left ventricular remodeling in a mouse model of myocardial infarction.Myocardial fibrosis: biomedical research from bench to bedside.Small-animal molecular imaging methods.Recent advances in molecular magnetic resonance imaging of liver fibrosis Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.T₂ -weighted MRI of post-infarct myocardial edema in mice.Emerging MRI methods in translational cardiovascular research Molecular Imaging of Healing After Myocardial Infarction.Multimodality imaging of myocardial injury and remodeling.Multimodality cardiovascular molecular imaging, Part II Molecular imaging in cardiovascular disease: Which methods, which diseases?Visualization and quantification of whole rat heart laminar structure using high-spatial resolution contrast-enhanced MRI.MR imaging probes: design and applications.Gastric calcifying fibrous pseudotumour associated with an ulcer: report of one case with a literature review.Molecular Imaging of Myocardial Injury: A Magnetofluorescent Approach Targeted probes for cardiovascular MRI Molecular and Microstructural Imaging of the Myocardium Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic Assessment of Myocardial Remodeling Using an Elastin/Tropoelastin Specific Agent with High Field Magnetic Resonance Imaging (MRI)Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models.Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI Molecular MRI of collagen to diagnose and stage liver fibrosis Mesenchymal Stem Cells Combined with Hepatocyte Growth Factor Therapy for Attenuating Ischaemic Myocardial Fibrosis: Assessment using Multimodal Molecular Imaging.Molecular magnetic resonance imaging of pulmonary fibrosis in mice Cardiomyocyte death: insights from molecular and microstructural magnetic resonance imaging.MRI & MRS assessment of the role of the tumour microenvironment in response to therapy.Contrast-enhanced MRI of murine myocardial infarction - part I.Contrast-enhanced MRI of murine myocardial infarction - part II.Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.Molecular MRI of the Cardiovascular System in the Post-NSF Era Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.Exploring the structural requirements of collagen-binding peptides.Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer.

P2860

Q27309869-BE09244E-C24D-4A32-8410-583B546A16B9 Q30276924-7A6360C0-801F-49BA-AC3A-7BB1AED1B7A3 Q30300274-9F51FAF6-77B5-4B29-A338-3EFCFDD2BC0F Q30362840-102669BD-68D6-41D1-B853-38585041827C Q30414174-44C1212E-2590-4F04-845A-4B3992A7361A Q30414378-9EA64D2D-C4B6-4412-9BF2-3163AB67AD46 Q30417445-5516181F-3C46-4BF7-8416-B5D9D1F992C5 Q30423185-BA1F1AD8-1D11-4058-8DED-73CF28A1820A Q30425743-181E796F-DE87-4B13-9540-90C87E79F8D4 Q30428495-DBDFAA23-545B-48B5-B5BF-5677BCEABB75 Q30432655-71A089E5-AACE-45D5-99DD-CFA10B829866 Q30438207-EB145383-3CE0-436F-9FC4-4803627DC678 Q30442045-09B1ECF2-10CD-49A6-8BDB-6082C3FE0BD3 Q30513707-DE2D5199-637A-4AEC-81C6-753B8FB72910 Q30868199-DCC66397-F1CA-484F-928E-FBCBFB7331EB Q33159110-A8C29AAF-3F96-44AE-BBD8-44C9A030DB0F Q33596970-39F5B086-7A67-4968-9814-C4C7FC719663 Q33901726-FC4E80C4-CE52-48B0-8941-A5A4E901D1DC Q34044733-7CD8EA6D-3358-4797-8CBF-44FFFEB5AD40 Q34074677-7DFB544D-ED5C-44D1-A180-ACE6FEF6493B Q35667247-7CF7BB0E-9FE8-4181-8CED-23217425D378 Q36095916-030E36E8-C895-4C59-8194-50177620CEB9 Q36141557-0CC5CA77-BE8C-493B-9DB8-8211BBBCE65A Q36177218-F867A682-060D-42C4-9AAA-8BFDE14D00D1 Q36517070-47F62F07-623E-4DD3-8F11-3CB0EA2B6624 Q37188547-4C08DC87-21C2-436C-A7D0-BD7C165CC9BE Q37248611-654FF24F-5941-4FF5-B69B-C8A57EDFCF37 Q37386157-43FFA69B-BCD4-470C-A347-2F46D27CC55B Q37596487-8DC3A00F-1C34-4309-B7CF-EECAEAA99F76 Q37836529-95769312-086D-48B0-B5CE-7678745B5645 Q37875004-9CF1B0B5-6F7A-4DDD-9043-256762BC1C14 Q37981643-FD12490D-A144-4E3C-BF41-AA21ED9CD2DD Q37981921-5F7DE207-8F31-47E4-AB82-A9608BF4C921 Q38052020-AF523387-3DEE-4819-85E5-83B918C2A9CC Q38090583-E817F71F-D2D5-45EB-87EC-9EF09BD9D4C0 Q38596113-8CA67EE0-DCFC-4440-A946-933050E59896 Q39392998-CF15555F-7DE9-4923-8ABD-9FD833E5E186 Q40150111-1E4C62DC-9426-4DD8-B221-DED9BB25FC10 Q40625539-DFA405AE-641B-450E-8648-5AB48B135298 Q41388169-F9BCC5DD-A163-40F3-82BC-0847A3FC840B

P2860

Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.

http://www.wikidata.org/entity/Q30352821

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@ast

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@en

type

label

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@ast

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@en

prefLabel

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@ast

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@en

P1433

Q30352821-57C402E2-44FD-4497-8F57-97E4DA297DD3

P1476

Q30352821-145996BF-062C-42B1-9DCF-721BE80033CB

P2093

Q30352821-1F97CD28-70B1-4079-A5E9-5636645BD8A1

Q30352821-95B241E2-8EB6-4CE1-A0D0-43FFEF2EE89D

Q30352821-D6345AD3-F194-4E93-B8D6-6CFD3504DC7F

Q30352821-E59FE1A4-DCDA-4263-A314-5517BC4CECC9

P2860

Q30352821-007105FC-01F3-4ACE-B3C8-674DF4699A1B

Q30352821-120BD582-DB23-4FD5-8E37-DF6D938EC77E

Q30352821-13A1BEAC-B518-4D40-AE2A-E51703986322

Q30352821-18497CE0-8D2F-498C-ACBF-1623F93815AF

Q30352821-2748FFA4-A9C4-4F1A-9E0D-A26320077757

Q30352821-2C8742EE-ADA1-48FE-9CF7-0D4F90EEA4A0

Q30352821-572E7ECB-F259-4A01-9BFB-A57815C91D8A

Q30352821-5AA9C3BA-5194-4961-A6B9-20373B5EDEA6

Q30352821-5D6DDA45-0C68-4AB2-AD46-E383AD3ADDD5

Q30352821-81BDC65C-332F-4659-AD8E-25E339FC7098

P304

Q30352821-2BB4A592-39C3-4448-8AE6-D721A6BCF1D4

P31

Q30352821-045F3B66-F226-4CF6-97BA-BBB5A97FD0B4

P356

Q30352821-C836F5D1-460D-413E-AB9A-9B01252B9E7B

P407

Q30352821-ADCFA960-9220-4FA7-BC60-B3A9DEA861C6

P433

Q30352821-A72813C1-1E50-4DE6-98BA-CEBEA69BF526

P478

Q30352821-F65EA5BF-2C8C-4FDA-9526-F533E6F77BB2

P50

Q30352821-5CBFFD39-F16F-4DE5-BF54-9D49B855D2F2

Q30352821-98080D9D-3A6A-4FCE-9FDA-8B2711C8AE31

Q30352821-C0A29349-0B84-4E18-AAE6-9F5D17AB0F4C

Q30352821-CECA7E4F-C8C5-4FD6-937E-362013D31130

Q30352821-D6656EE7-6C92-4D25-8F85-674E14F66CFF

Q30352821-DDF85E10-FA0A-445B-8919-28BB9979ABF1

P577

Q30352821-37F43920-11F7-4272-9571-A19417F5530F

P698

Q30352821-6C8044F1-6AAD-4633-8FF7-27A6F93465B9

P932

Q30352821-E0DBCFEC-F8B1-4992-A5D3-2BB489C9B80B

P356

RADIOL.2473070975

P1433

P1476

Postinfarction myocardial scar ...... agen-targeting contrast agent.

@en

P2093

Luhua Shen

http://www.w3.org/2001/XMLSchema#string

Patrick A Helm

http://www.w3.org/2001/XMLSchema#string

R Jack Roy

http://www.w3.org/2001/XMLSchema#string

Vincent Jacques

http://www.w3.org/2001/XMLSchema#string

P2860

Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction.

MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions.

Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.

Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction.

Black blood gradient echo cine magnetic resonance imaging of the mouse heart.

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

Collagen network remodelling and left ventricular function in constrictive pericarditis.

Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts.

P304

788-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2473070975

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

247

http://www.w3.org/2001/XMLSchema#string

P50

Christopher M Kramer

Frederick H Epstein

Ronald J Beyers

P577

2008-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18403626

http://www.w3.org/2001/XMLSchema#string

P932

5410958

http://www.w3.org/2001/XMLSchema#string